doi: 10.1016/s0026-0495(98)90357-2
This is a more physiological approach compared to directly injecting growth hormone
(PubMed) Braekke K, Ueland PM, Harsem NK, Karlsen A, Blomhoff R, Staff AC
Molecular Characteristics Compound Name: MOD-GRF (1-29) + Ipamorelin + GHRP-2 Blend CAS Numbers: 863288-34-0, 170851-70-4, 158861-67-7 Peptide Class: GHRH analog + GHS-R agonist peptide blend Form: Lyophilized peptide powder blend Purity: 99% HPLC verified Unit Size: Research peptide blend format Stability Profile and Storage Recommendations Store lyophilized peptides at 20C Protect from moisture and light exposure Avoid repeated freezethaw cycles Reconstitute using sterile laboratory-grade solvent Seal vial tightly after use Solubility and Preparation Considerations Soluble in sterile bacteriostatic water Compatible with buffered aqueous laboratory solutions Suitable for peptide research protocols Applicable in receptor signaling assay preparations Compatible with cell culture experimental models Technical Specifications product Name MOD-GRF (1-29) + Ipamorelin + GHRP-2 Blend brand BioPeptides cas 863288-34-0 / 170851-70-4 / 158861-67-7 purity 99% (HPLC verified) form Lyophilized peptide powder blend synthesis Solid-phase peptide synthesis (SPPS) analytical HPLC and mass spectrometry verification molecular Structure Triple peptide blend targeting GH-axis signaling stability Stable under 20C storage conditions Analytical Validation and Quality Assurance High-resolution HPLC purity testing Peptide identity verification Structural integrity analysis Batch-to-batch consistency validation Peptide stability testing Regulatory and Compliance Statement MOD-GRF (1-29) + Ipamorelin + GHRP-2 supplied by BioPeptides is intended strictly for laboratory research use only
This combination of consultation, nurse-led infusion and ongoing support ensures every patient receives safe, compassionate care from start to finish
without DAC (modified GRF 1-29) is shorter-acting with a more pulse-like effect
